Liquid crystal compounds

Compounds with a 1,4-substituted cyclohexene ring and dioxane/tetrahydropyran rings address the need for high dielectric anisotropy and low viscosity in liquid crystals, enhancing stability and solubility for advanced display technologies.

JP7577453B2Active Publication Date: 2024-11-05MERCK PATENT GMBH
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2020046120
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-03-18
Filing Date
2020-03-17
Publication Date
2024-11-05
Estimated Expiration
2040-03-17

AI Technical Summary

Technical Problem

Existing liquid crystal compounds do not meet the requirements for high dielectric anisotropy, low viscosity, and thermal stability needed for advanced display technologies like IPS and FFS, while also ensuring low melting points and solubility to prevent crystallization at low temperatures.

Method used

Development of compounds containing a 1,4-substituted cyclohexene ring combined with a dioxane or tetrahydropyran ring and a substituted biphenyl group, which exhibit high dielectric anisotropy, low viscosity, and thermal stability, allowing for broad nematic phases and easy miscibility in liquid crystal mixtures.

Benefits of technology

The new compounds provide improved dielectric anisotropy, reduced rotational viscosity, and high clearing points, resulting in faster response times and higher contrast with enhanced solubility and stability, suitable for various display technologies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007577453000001
    Figure 0007577453000001
  • Figure 0007577453000002
    Figure 0007577453000002
  • Figure 0007577453000003
    Figure 0007577453000003
Patent Text Reader

Abstract

To provide liquid-crystalline compounds.SOLUTION: The invention provides compounds of the formula I, a process for preparation thereof, liquid-crystalline media comprising at least one compound of the formula I, and electro-optical displays containing a liquid-crystalline medium of this type. The compounds of the formula I include, as a structural element, a combination of a 1,4-substituted cyclohexene ring besides a dioxane or tetrahydropyran ring and a substituted biphenyl group. (In the formula, Y1 denotes -O- or -CH2-, and the groups R1, L1 to L6 and X1 have the meanings indicated in claim 1.)SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to compounds of formula I as defined below, which contain as structural elements a combination of a dioxane or tetrahydropyran ring and a substituted biphenyl group as well as a 1,4-substituted cyclohexene ring. In addition, the present invention encompasses the preparation process, liquid-crystalline media comprising at least one compound of formula I, and the use of compounds of formula I as component(s) in liquid-crystalline media. In addition, the present invention relates to liquid-crystalline and electro-optical display elements comprising a liquid-crystalline medium according to the invention. [Background technology]

[0002] In recent years, the field of application of liquid crystal compounds has been significantly expanded to various display devices, electro-optical devices, electronic components, sensors, etc. For this reason, especially in the field of nematic liquid crystals, many different structures have been proposed. To date, nematic liquid crystal mixtures have found the most widespread use in flat panel display devices. They have been employed in particular in passive TN or STN matrix displays or in systems with a TFT active matrix.

[0003] The liquid-crystalline compounds according to the invention can be used as constituent(s) of liquid-crystalline media, in particular for displays based on the twisted cell principle, the guest-host effect, the deformation of aligned phases, the DAP or ECB (electrically controlled birefringence) effect, the IPS (in-plane switching) effect or the dynamic scattering effect.

[0004] The use of polar dioxane and tetrahydropyran compounds with four rings as liquid crystal substances is not known to those skilled in the art. Various compounds containing O-heterocycles have already been described as liquid crystal or mesogenic substances, the preparation of which is described, for example, in WO 2004 / 106460. The compounds proposed therein do not contain a cyclohexene ring. As polar end groups the compounds contain, for example, -OCF3 or fluorine.

[0005] Cyclohexene compounds containing a dioxane ring are known from WO 2018 / 141759 (Patent Document 2), but contain only three ring groups in total.

[0006] The present invention aims to find new stable compounds suitable as constituents (one or more) of liquid-crystalline media. In particular, the compounds must simultaneously have a relatively low viscosity as well as a high dielectric anisotropy. In many current mixture concepts in the field of liquid crystals, it is advantageous to use compounds with a positive dielectric anisotropy Δε in combination with a moderate to high optical anisotropy.

[0007] In view of the very wide field of application of compounds of this type having high Δε, it would have been desirable to have available further compounds having precisely tailored properties for the respective application, preferably having a high clearing point and a low viscosity.

[0008] It was therefore an object of the present invention to find new, stable compounds which are suitable in particular as constituent(s) of liquid-crystalline media for, for example, TN, STN, IPS, FFS and TN-TFT displays.

[0009] In addition, the compounds of the present invention are intended to be thermally and photochemically stable under conditions typical in the field of application. As mesogens, they must promote broad nematic phases in mixtures with liquid crystal co-constituents and be easily miscible in nematic base mixtures, especially at low temperatures. Substances with low melting points and low enthalpies of fusion are preferred as well, since these parameters indicate the desirable properties mentioned above, such as high solubility, broad liquid crystal phases, and low tendency to spontaneous crystallization in mixtures at low temperatures. Solubility, especially at low temperatures, is important for the safe operation and transportation of displays in vehicles and aircraft as well as outdoors, while avoiding crystallization. [Prior art documents] [Patent documents]

[0010] [Patent Document 1] International Publication No. 2004 / 106460 [Patent Document 2] International Publication No. 2018 / 141759 [Patent Document 3] U.S. Pat. No. 4,940,822 Summary of the Invention [Problem to be solved by the invention]

[0011] Surprisingly, it has been found that the compounds according to the invention are very suitable as components of liquid-crystalline media. They can be used to obtain liquid-crystalline media for displays requiring particularly high dielectric anisotropy, in particular IPS or FFS displays, but also TN or STN displays. The compounds according to the invention are sufficiently stable and colourless. They are distinguished by a particularly high dielectric anisotropy (Δε), which requires smaller layer thicknesses and therefore lower threshold voltages in the use in optical switching elements. They have good solubility compared to compounds with comparable properties. The compounds according to the invention also have a relatively high clearing point and at the same time low values ​​of the rotational viscosity. The compounds have a relatively low melting point. The compounds according to the invention surprisingly have high values ​​of the elastic constants (K11 / K 22 / K 33 ) and the elastic constant K 11 It is possible to prepare liquid crystal mixtures with a low ratio of rotational viscosity to viscosity without adversely affecting other application parameters, which results in media with short response times and high contrast.

[0012] By providing the compounds according to the invention, the range of liquid crystal substances which are suitable from the point of view of various applications for preparing liquid crystal mixtures is very generally considerably broadened.

[0013] The compounds according to the present invention have a wide range of applications.Depending on the selection of substituents, these compounds can function as the basic material that mainly constitutes liquid crystal medium.But it is also possible to add liquid crystal basic material from other series of compounds to the compounds of formula I according to the present invention, for example, to affect the dielectric properties and / or the optical anisotropy of this type of dielectric and / or to optimize its threshold voltage and / or its viscosity. [Means for solving the problem]

[0014] The present invention therefore relates to compounds of formula I:

[0015] [ka] During the ceremony, X 1 represents F, CF3, OCF3, Cl, OCHF2, CHF2, SCN or CN, Y 1 represents O or CH2, R 1 represents an alkyl group having 1 to 15 C atoms (provided, in addition, that one or more CH groups in these groups may in each case independently be -C≡C-, -CF2O-, -OCF2-, -CH=CH ...

[0016] [ka] -O-, -S-, -CO-O- or -O-CO-, with the proviso that in addition one or more H atoms may be replaced by halogen; L 1 and L 2 represent, independently of one another, H or F, preferably F, L 3 represents H or F, preferably F, L 4 represents H or F, preferably H, and L 5 and L 6 represent independently of one another H or CH3, preferably H.

[0017] The invention further relates to the use of compounds of formula I in liquid crystal media.

[0018] The invention likewise relates to a liquid-crystalline medium having at least two liquid-crystalline components which contain at least one compound of the formula I.

[0019] In the pure state, the compounds of formula I are colorless and form liquid crystal mesophases in a temperature range that is in favorable values ​​for electro-optical use, either by themselves or in mixtures. The compounds according to the invention make it possible to achieve a wide nematic phase range. In liquid crystal mixtures, the substances according to the invention result in a significant increase in optical anisotropy and / or improved low-temperature storage stability compared to comparable mixtures with high dielectric anisotropy. At the same time, the compounds according to the invention are distinguished by good UV stability. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0020] The group R in formula I and its subformulas 1 R preferably represents an alkyl or alkenyl having up to 8 carbon atoms. 1 particularly preferably denotes a linear alkyl group having 1 to 7 C atoms or an unbranched alkenyl group having 2 to 8 C atoms, in particular an unbranched alkyl group having 1 to 5 C atoms.

[0021] Alternative group R 1 is selected from cyclopentyl, 2-fluoroethyl, cyclopropylmethyl, cyclopentylmethyl, cyclopentylmethoxy, cyclobutylmethyl, 2-methylcyclopropyl, 2-methylcyclobutyl, and 2-alkyloxyethoxy.

[0022] Group X of formula I 1 preferably denotes F, CF3, OCF3 or -SCN, particularly preferably F, CF3 or OCF3, very particularly preferably F.

[0023] Branched or substituted side groups R 1 Compounds of formula I containing the group R are often valued for their better solubility than conventional liquid crystal base materials. 1 is preferably linear.

[0024] L 1 represents F and L 2 stands for H or F, especially L 1 and L 2 Compounds of formula I are preferred, in which L 3 represents H or F and L 4 represents H, and especially L 3 = H and L 4 Compounds in which L = F are preferred. 6 represents H and L 5 represents H or methyl, especially L 5 and L 6 Compounds where =H are preferred.

[0025] base R 1 is particularly preferably selected from the substructures below.

[0026] [ka] In this formula the alkyl chain is preferably unbranched (n-alkyl).

[0027] Particularly preferred compounds of formula I are the compounds of formulae I-1 to I-6.

[0028] [ka] R in the formula 1 R independently has the meaning given above. Among the compounds of formulae I-1 to I-6, the compounds of formulae I-1 and I-2 are preferred. 1 particularly preferably denotes an n-alkyl group having 2, 3, 4, 5, 6 or 7 C atoms.

[0029] The following are exemplary compounds.

[0030] [ka]

[0031] [ka]

[0032] [ka]

[0033] [ka]

[0034] The compounds of formula I are prepared by methods known per se under the correct reaction conditions known and appropriate for the reaction in question, as described in the literature (e.g. standard works such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart). Per se known variants, which are not mentioned in more detail here, can also be used here.

[0035] Compounds of formula I can be advantageously prepared as shown in the following illustrative syntheses and examples (Schemes 1-3).

[0036] [ka]

[0037] Alternatively, the reaction sequence from Scheme 1 can be modified to provide synthetic Scheme 2 for preparing the corresponding tetrahydropyran compounds.

[0038] [ka]

[0039] The corresponding starting materials can generally be readily prepared by one skilled in the art using synthetic methods known in the literature or are commercially available.

[0040] Instead of the Grignard compounds outlined by Schemes 1 and 2, it is also possible to use aryllithium compounds which are similarly accessible by halogen-metal exchange with alkyllithium compounds at low temperatures (see, for example, U.S. Pat. No. 4,940,822).

[0041] The present invention therefore also relates to a process for preparing a compound of formula I, comprising the step of reacting an aryl halide compound of formula II with a compound of formula III to obtain a compound of formula IV, which is further converted to a compound of formula I.

[0042] [ka] During the ceremony, X 1 , L 1 , L 2 , L 3 and L 4 is as defined in formula I, and Hal represents Br, I or Cl, preferably Br.

[0043] [ka] During the ceremony, R 1 and Y 1 is as defined in formula I.

[0044] [ka]

[0045] [ka] In the formula, the groups are as defined above.

[0046] To react compound II with III, compound II is generally first metallated, for example by reaction with an alkyl magnesium halide, magnesium or alkyl lithium compound. The alkyl metal compound is subsequently reacted with cyclohexyl ketone III. The cyclohexanol product of formula IV is converted to the cyclohexene of formula I by acid-catalyzed dehydration.

[0047] The reaction methods and reagents used are in principle known from the literature. Further reaction conditions emerge from the examples.

[0048] Further preferred process variants not mentioned above emerge from the examples or claims.

[0049] The reaction steps and work-up of the reaction mixture can essentially be carried out in batch or continuous reaction modes, including, for example, in a continuous stirred tank reactor, a cascade of stirred tank reactors, a loop or cross-flow reactor, a flow tube or a microreactor. The reaction mixture may be optionally worked up by removal of solvents and / or azeotropes by solid-phase filtration, chromatography, separation between immiscible phases (e.g., extraction), adsorption onto a solid support, distillation, selective distillation, sublimation, crystallization, cocrystallization or nanofiltration over a membrane.

[0050] In the present disclosure, the 2,5-disubstituted dioxane ring of the formula:

[0051] [ka] Preferably, the dioxane ring is in the 2,5-trans configuration, i.e., the substituents R are preferably both in equatorial positions in the preferred chair conformation.

[0052] [ka] Also preferred is a tetrahydropyran ring in the 2,5-trans configuration, ie the substituents are preferably both at equatorial positions of the preferred chair conformation.

[0053] The present invention also relates to a liquid-crystalline medium comprising one or more compounds of formula I according to the present invention. The liquid-crystalline medium comprises at least two components. They are preferably obtained by mixing the components together. Thus, the method according to the present invention for preparing a liquid-crystalline medium is characterized in that at least one compound of formula I is mixed with at least one further mesogenic compound and additives may be added.

[0054] The achievable combinations of clearing point, viscosity at low temperature, thermal / UV stability, dielectric anisotropy, response time and contrast are far superior to conventional materials from the prior art.

[0055] The liquid-crystalline media according to the invention preferably comprise from 2 to 40, particularly preferably from 4 to 30, further constituents in addition to one or more compounds according to the invention. These media in particular comprise from 7 to 25 further constituents in addition to one or more compounds according to the invention. These further constituents are preferably selected from nematic or nematically (monotropic or isotropic) substances, in particular azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl esters of cyclohexanecarboxylic acid, phenyl or cyclohexyl esters of cyclohexylbenzoic acid, phenyl or cyclohexyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexylphenyl esters of benzoic acid, of cyclohexanecarboxylic acid or of cyclohexylcyclohexanecarboxylic acid, phenylcyclohexanes, cyclohexylbiphenyls, phenylcyclohexylcyclohexanes, ... The phenylene group is selected from the series of phenyl or cyclohexylcyclohexylcyclohexanes, 1,4-biscyclohexylbenzenes, 4,4'-biscyclohexylbiphenyls, phenyl or cyclohexylpyrimidines, phenyl or cyclohexylpyridines, phenyl or cyclohexyldioxanes, phenyl or cyclohexyl-1,3-dithianes, 1,2-diphenylethanes, 1,2-dicyclohexylethanes, 1-phenyl-2-cyclohexylethanes, 1-cyclohexyl-2-(4-phenylcyclohexyl)ethanes, 1-cyclohexyl-2-biphenylethanes, 1-phenyl-2-cyclohexylphenylethanes, optionally halogenated stilbenes, benzyl phenyl ethers, tolanes, substituted cinnamic acids. The 1,4-phenylene group in these compounds may also be fluorinated.

[0056] The most important compounds suitable as further constituents of the media according to the invention can be characterized by formula 1, formula 2, formula 3, formula 4 and formula 5.

[0057] [ka] In formula 1, formula 2, formula 3, formula 4 and formula 5, L and E, which may be the same or different, each independently represent a divalent radical from the group formed by the structural elements -Phe-, -Cyc-, -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -Pyr-, -Dio-, -Py-, -G-Phe-, -G-Cyc- and their mirror images, where Phe represents unsubstituted or fluorine-substituted 1,4-phenylene, Cyc represents trans-1,4-cyclohexylene, Pyr represents pyrimidine-2,5-diyl or pyridine-2,5-diyl, Dio represents 1,3-dioxane-2,5-diyl, Py represents tetrahydropyran-2,5-diyl and G represents 2-(trans-1,4-cyclohexyl)ethyl.

[0058] One of the groups L and E is preferably Cyc, Phe or Pyr. E is preferably Cyc, Phe or Phe-Cyc. The medium according to the invention preferably comprises one or more components selected from the compounds of formula 1, 2, 3, 4 and 5, in which L and E are selected from the group consisting of Cyc, Phe and Pyr, and at the same time one or more components selected from the compounds of formula 1, 2, 3, 4 and 5, in which one of the groups L and E is selected from the group consisting of Cyc, Phe, Py and Pyr and the other group is selected from the group consisting of -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-, and optionally one or more components selected from the compounds of formula 1, 2, 3, 4 and 5, in which L and E are selected from the group consisting of -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-.

[0059] R' and / or R" are each independently alkyl, alkenyl, alkoxy, alkoxyalkyl, alkenyloxy or alkanoyloxy having up to 8 C atoms, -F, -Cl, -CN, -NCS or -(O) i CH 3-k F k where i is 0 or 1 and k is 1, 2, or 3.

[0060] In smaller subgroups of compounds of formula 1, formula 2, formula 3, formula 4 and formula 5, R' and R" each independently of one another represent alkyl, alkenyl, alkoxy, alkoxyalkyl, alkenyloxy or alkanoyloxy having up to 8 C atoms. This smaller subgroup is hereinafter referred to as group A and the compounds are designated by subformulae 1a, subformula 2a, subformula 3a, subformula 4a and subformula 5a. In most of these compounds R' and R" are different from one another and one of these groups is usually alkyl, alkenyl, alkoxy or alkoxyalkyl.

[0061] In another smaller subgroup of compounds of formula 1, formula 2, formula 3, formula 4 and formula 5, referred to as group B, R″ is —F, —Cl, —NCS or —(O) i CH 3-k F k where i is 0 or 1 and k is 1, 2 or 3. Compounds in which R" has this meaning are designated by subformula 1b, subformula 2b, subformula 3b, subformula 4b and subformula 5b. Particular preference is given to the compounds of subformula 1b, subformula 2b, subformula 3b, subformula 4b and subformula 5b in which R" means -F, -Cl, -NCS, -CF3, -OCHF2 or -OCF3.

[0062] In the compounds of sub-formulae 1b, 2b, 3b, 4b and 5b R' has the meaning given in the case of the compounds of sub-formulae 1a to 5a and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl.

[0063] In a further smaller subgroup of compounds of formula 1, formula 2, formula 3, formula 4 and formula 5, R" represents -CN. This subgroup is hereinafter called group C and the compounds of this subgroup are designated by subformulae 1c, subformula 2c, subformula 3c, subformula 4c and subformula 5c. In the compounds of subformulae 1c, subformula 2c, subformula 3c, subformula 4c and subformula 5c, R' has the meaning given in the case of the compounds of subformulae 1a to 5a and is preferably alkyl, alkoxy or alkenyl.

[0064] Besides the preferred compounds of groups A, B and C, other compounds of formula 1, 2, 3, 4 and 5 having other than the proposed substituents can also be used. All these substances are known from the literature or can be obtained by methods analogous thereto.

[0065] Besides the compounds of formula I according to the invention, the medium according to the invention preferably comprises one or more compounds selected from group A, group B and / or group C. The weight ratio of the compounds from these groups in the medium according to the invention is preferably: Group A: 0 to 90%, preferably 20 to 90%, particularly preferably 30 to 90%; Group B: 0 to 80%, preferably 10 to 80%, particularly preferably 10 to 65%; Group C: 0 to 80%, preferably 0 to 80%, particularly preferably 0 to 50%; However, the total weight ratio of the compounds of group A, group B and / or group C present in each medium according to the present invention is preferably 5 to 90%, particularly preferably 10 to 90%.

[0066] The medium according to the invention preferably comprises from 1 to 40%, particularly preferably from 3 to 30%, of the compound according to the invention.

[0067] The liquid crystal mixtures according to the invention are prepared in a manner conventional per se. In general, the desired amount of the component to be used in a smaller amount is dissolved in the component that constitutes the main component, preferably at high temperature. It is also possible to mix solutions of the components in organic solvents, such as acetone, chloroform or methanol, and then remove the solvent again, for example by distillation, after thorough mixing. It is also possible to prepare the mixtures in other conventional ways, such as using premixes, such as homologous mixtures, or using the so-called "multi-bottle" system.

[0068] The dielectric may also contain further additives known to those skilled in the art and described in the literature. For example, 0-15%, preferably 0-10%, of pleochroic dyes, chiral dopants, stabilizers or nanoparticles can be added. The individual compounds added are used in concentrations of 0.01-6%, preferably 0.1-3%. However, in this specification, the concentration data of the other constituents of the liquid crystal mixture, i.e. the liquid crystals and mesogenic compounds, are given without taking into account the concentrations of these additives.

[0069] The liquid crystal mixtures according to the invention make it possible to significantly broaden the range of available parameters.

[0070] The invention also relates to electro-optical displays containing this type of medium (in particular TFT displays having two plane-parallel outer plates forming a cell together with a frame, an integrated nonlinear element for switching individual pixels on the outer plates, and a nematic liquid crystal mixture with positive dielectric anisotropy and high resistivity arranged within the cell), and to the use of these media for electro-optical purposes.

[0071] The term "alkyl" embraces unbranched and branched alkyl radicals having 1 to 15 carbon atoms, in particular the unbranched radicals methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl and n-heptyl. Radicals having 2 to 5 carbon atoms are generally preferred.

[0072] The term "alkenyl" embraces unbranched and branched alkenyl groups having up to 15 carbon atoms, in particular unbranched groups. Particularly preferred alkenyl groups are C2-C7-1E-alkenyl, C4-C7-3E-alkenyl, C5-C7-4-alkenyl, C6-C7-5-alkenyl and C7-6-alkenyl, in particular C2-C7-1E-alkenyl, C4-C7-3E-alkenyl and C5-C7-4-alkenyl. Examples of preferred alkenyl groups are vinyl, 1E-propenyl, 1E-butenyl, 1E-pentenyl, 1E-hexenyl, 1E-heptenyl, 3-butenyl, 3E-pentenyl, 3E-hexenyl, 3E-heptenyl, 4-pentenyl, 4Z-hexenyl, 4E-hexenyl, 4Z-heptenyl, 5-hexenyl, 6-heptenyl, etc. Groups having up to 5 carbon atoms are generally preferred.

[0073] The expression "halogenated alkyl group" preferably includes mono- or polyfluorinated and / or chlorinated groups. Perhalogenated groups are included. Fluorinated alkyl groups are particularly preferred, in particular CF3, CH2CF3, CH2CHF2, CHF2, CH2F, CHFCF3 and CF2CHFCF3. The expression "halogenated alkenyl group" and related expressions are explained accordingly.

[0074] The total amount of compounds of formula I in the mixture according to the invention is not critical, and the mixture may therefore contain one or more further components in order to optimise various properties.

[0075] The structure of the matrix display according to the invention from the polarizers, the electrode substrate and the surface-treated electrodes corresponds to a conventional design for this type of display. The term conventional design is used here broadly and includes all derivatives and modifications of matrix displays, in particular matrix display elements based on poly-Si-TFTs.

[0076] However, an essential difference between a display according to the invention and a display based on a conventional twisted nematic cell lies in the choice of liquid crystal parameters of the liquid crystal layer.

[0077] The following examples are intended to illustrate the present invention without being intended to limit it, and those skilled in the art will be able to obtain from the examples details not specifically given in the general description, and will be able to generalize them according to their general expertise and apply them to their specific problems.

[0078] Above and below, percentage data refers to weight percent. All temperatures are given in degrees Celsius. Additionally, C is the liquid crystalline state, N is the nematic phase, Sm is the smectic phase (more specifically SmA, SmB, etc.), Tg is the glass transition temperature, and I is the isotropic phase. Data between these symbols refer to the transition temperatures. Δn is the optical anisotropy (589 nm, 20 °C), Δε is the dielectric anisotropy (1 kHz, 20 °C), and γ1 is the rotational viscosity (20 °C; in mPa·s).

[0079] The physical, physicochemical and electro-optical parameters are determined by generally known methods, as described, inter alia, in the document "Merck Liquid Crystals - Licristal® - Physical Properties of Liquid Crystals - Description of Measurement Methods" (1998, Merck, Darmstadt).

[0080] The dielectric anisotropy Δε of the individual substances is determined at 20 ° C and 1 kHz. For this purpose, 5-10% by weight of the substances considered and measured are dissolved in the dielectrically positive mixture ZLI-4792 (Merck) and the measured values ​​are extrapolated to a concentration of 100%. The optical anisotropy Δn is determined at 20 ° C and a wavelength of 589.3 nm, and the rotational viscosity γ1 is determined at 20 ° C by linear extrapolation as well.

[0081] In this application, unless expressly stated otherwise, the plural of the terms refers to both the singular and the plural, and vice versa. Further combinations of the embodiments and variations of the invention according to the detailed description arise from the appended claims or from multiple combinations of these claims.

[0082] The following abbreviations are used: RT room temperature THF Tetrahydrofuran MTB Ether Methyl tert-butyl ether sat. saturation dist. Distillation. EXAMPLES

[0083] The present invention will now be described in more detail with reference to the following non-limiting examples.

[0084] <Example 1>: 2-[4-[4-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane [ka]

[0085] <Step 1.1>: 4-(5-propyl-1,3-dioxan-2-yl)cyclohexanone [ka] Toluene-4-sulfonic acid monohydrate (6.4 g, 32 mmol) is added to a solution of 2-propylpropane-1,3-diol 1 (23.9 g, 193 mmol) and 4-oxocyclohexanecarbaldehyde 2 (CAS 96184-81-5, 30.0 g, 170 mmol) in dichloromethane (270 ml) and the mixture is refluxed on a water separator. After 90 min, the reaction mixture is cooled to RT and chromatographed on silica gel (dichloromethane / ethyl acetate 9:1). 4-(5-propyl-1,3-dioxan-2-yl)-cyclohexanone 3 is isolated as a yellow clear oil that solidifies to give a crystalline material.

[0086] <Step 1.2>: 1-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol [ka] A solution of isopropylmagnesium chloride / lithium chloride (116 ml, 150 mmol, 1.3 mol / l in THF) is introduced initially and a solution of 5-(4-bromo-2-fluorophenyl)-1,2,3-trifluorobenzene 4 (CAS 187804-77-9, 25.0 g, 80 mmol) in THF (150 ml) is added dropwise at 30° C. After 60 min, a solution of 4-(5-propyl-1,3-dioxan-2-yl)cyclohexanone 3 (25.0 g, 80 mmol) in THF (150 ml) is added dropwise at max. 30° C. After a further 60 min, distilled water is added to the reaction mixture, which is then adjusted to pH=5 with hydrochloric acid (1 M). The aqueous phase is separated and extracted with MTB ether. The combined organic phases are washed with saturated sodium bicarbonate solution, dried over sodium sulfate, filtered and evaporated in vacuum. The residue gives 1-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol 5 as yellowish crystals.

[0087] <Step 1.3>: 2-[4-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane [ka] Toluene-4-sulfonic acid monohydrate (0.5 g, 3 mmol) is added to a solution of 1-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol 5 (15.8 g, 15 mmol) in toluene (80 mL) and the mixture is heated under reflux on a water separator for 3 h. The reaction mixture is cooled to RT, diluted with heptane and chromatographed on silica gel (heptane / MTB ether 95:5). After crystallization from 2-propanol and heptane, 2-[4-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane 6 is isolated as a colorless solid. Compound 6 exhibits the following phase behavior:

[0088] C74SmA168N191I Δε=30 Δn=0.18

[0089] <Example 2>: 2-[4-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-butyl-1,3-dioxane [ka] 2-[4-[3-Fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-butyl-1,3-dioxane 7 is synthesized similarly to 2-[4-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane 6. Compound 7 exhibits the following phase behavior:

[0090] C64SmA174N190I Δε=28 Δn=0.18

[0091] <Example 3>: 2-[4-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane [ka]

[0092] <Step 3.1>: [3,5-difluoro-4-(trifluoromethyl)phenyl]boronic acid [ka] A solution of 5-bromo-1,3-difluoro-2-(trifluoromethyl)benzene 8 (CAS 156243-64-0, 200 g, 760 mmol) in THF (800 mL) is cooled to -5 °C and isopropylmagnesium chloride (420 mL in THF, 840 mmol, 2.0 mol / l) is added. After 1 h, a solution of trimethyl borate (106 ml, 950 mmol) in THF (100 ml) is added at -5 °C and the reaction mixture is stirred overnight at RT. The reaction mixture is added to ice-cold hydrochloric acid (410 ml, 2 M) and extracted with MTB ether. The phases are separated and the organic phase is washed with distilled water, dried over sodium sulfate, filtered and evaporated in vacuum. The crude product is purified by crystallization from heptane to give [3,5-difluoro-4-(trifluoromethyl)phenyl]boronic acid 9 as a beige solid.

[0093] <Step 3.2>: 5-(4-bromo-2-fluorophenyl)-1,3-difluoro-2-(trifluoromethyl)benzene [ka] A solution of sodium metaborate tetrahydrate (8.9 g, 64 mmol) in distilled water (23 ml) is first introduced, then THF (10 ml), bis(triphenylphosphine)palladium(II) chloride (15.2% Pd) (0.6 g, 0.9 mmol) and hydrazinium hydroxide (0.04 ml, 0.9 mmol) are added and the mixture is stirred for 5 min. Then 4-bromo-2-fluoro-1-iodobenzene 10 (CAS 105931-73-5, 12.7 g, 42 mmol), [3,5-difluoro-4-(trifluoromethyl)phenyl]boronic acid 9 (10.0 g, 42 mmol) and THF (40 ml) are added and the reaction mixture is refluxed overnight. Distilled water is added to the reaction mixture, which is then diluted with MTB ether. The aqueous phase is separated and extracted with MTB ether. The combined organic phases are washed with saturated sodium chloride solution, dried over sodium sulfate, filtered and evaporated in vacuo. The crude product is chromatographed on silica gel (heptane) to give 5-(4-bromo-2-fluorophenyl)-1,3-difluoro-2-(trifluoromethyl)benzene 11 as a clear, colorless oil.

[0094] <Step 3.3>: 1-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol [ka] Isopropylmagnesium chloride (15.7 ml, 31.4 mmol, 2 mol / l in THF) is initially introduced and a solution of 5-(4-bromo-2-fluorophenyl)-1,3-difluoro-2-(trifluoromethyl)benzene 11 (5.8 g, 15.7 mmol) in THF (50 ml) is added dropwise at 30° C. After 60 min, a solution of 4-(5-propyl-1,3-dioxan-2-yl)cyclohexanone 3 (5.0 g, 15.7 mmol) in THF (15 ml) is added dropwise at max. 20° C. After a further 60 min, distilled water is added to the reaction mixture, which is then adjusted to pH=5 using hydrochloric acid (1 M). The aqueous phase is separated and extracted with MTB ether. The combined organic phases are washed with saturated sodium bicarbonate solution, dried over sodium sulfate, filtered and evaporated in vacuum. The residue gives 1-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol 12 as brown crystals.

[0095] <Step 3.4>: 2-[4-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane [ka] Toluene-4-sulfonic acid monohydrate (0.3 g, 1.6 mmol) is added to a solution of 1-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol 12 (10.1 g, 8.2 mmol) in toluene (45 ml) and the mixture is refluxed on a water separator for 2 h. The reaction mixture is cooled to RT, evaporated in vacuum and chromatographed on silica gel (heptane / MTB ether 95:5). After crystallization from 2-propanol and n-heptane, 2-[4-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxan 13 is isolated as a colorless solid. Compound 13 exhibits the following phase behavior:

[0096] C124SmA173N186I Δε=38 Δn=0.19

[0097] <Example 4>: 2-[4-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane [ka]

[0098] <Step 4.1>: 2-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-4,4,5,5-tetramethyl-1,3-dioxa-2-borolane [ka] Potassium acetate (53.2 g, 540 mmol), 1,1'-bis(biphenylphosphine)ferrocenepalladium dichloride (4.0 g, 5.4 mmol) and bis(pinacolato)diboron (70.2 g, 271 mmol) are added to a solution of 5-bromo-1,3-difluoro-2-(trifluoromethoxy)benzene 14 (CAS 115467-07-7, 50.0 g, 180 mmol) in 1,4-dioxane (430 ml) and the mixture is refluxed overnight. The reaction mixture is cooled to RT, distilled water is added and the mixture is diluted with MTB ether. The phases are separated, the aqueous phase is extracted with MTB ether and the combined organic phase is washed with saturated sodium chloride solution, dried over sodium sulfate, filtered and evaporated in vacuum. The crude product is chromatographed on silica gel (toluene) and crystallized from ethanol to give 2-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-4,4,5,5-tetramethyl-1,3-dioxa-2-borolane 15 as a colorless solid.

[0099] <Step 4.2>: 5-(4-bromo-2-fluorophenyl)-1,3-difluoro-2-(trifluoromethoxy)benzene [ka] A solution of sodium metaborate tetrahydrate (10.2 g, 74 mmol) in distilled water (33.2 ml) is first introduced, THF (10 ml), bis(triphenylphosphine)palladium(II) chloride (15.2% Pd) (1.7 g, 2.5 mmol) and hydrazinium hydroxide (0.12 ml, 2.5 mmol) are added and the mixture is stirred for 5 min. Then 4-bromo-2-fluoro-1-iodobenzene 10 (18.5 g, 61 mmol), 2-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-4,4,5,5-tetramethyl-1,3-dioxa-2-borolane 15 (20.0 g, 61 mmol) and THF (65 ml) are added and the reaction mixture is refluxed overnight. Distilled water is added to the reaction mixture, which is then diluted with MTB ether. The aqueous phase is separated and extracted with MTB ether. The combined organic phases are washed with saturated sodium chloride solution, dried over sodium sulfate, filtered and evaporated in vacuo. The crude product is chromatographed on silica gel (heptane) and recrystallized from heptane to give 5-(4-bromo-2-fluorophenyl)-1,3-difluoro-2-(trifluoromethoxy)benzene 16 as a colorless solid.

[0100] <Step 4.3>: 1-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol [ka] Isopropylmagnesium chloride / lithium chloride (in THF, 23.7 ml, 30.8 mmol, 1.3 mol / l) is initially introduced and a solution of 5-(4-bromo-2-fluorophenyl)-1,3-difluoro-2-(trifluoromethoxy)benzene 16 (5.5 g, 14.6 mmol) in THF (25 ml) is added dropwise at 30° C. After 60 min, a solution of 4-(5-propyl-1,3-dioxan-2-yl)cyclohexanone 3 (5.0 g, 15.4 mmol) in THF (37 ml) is added dropwise at max. 20° C. and the mixture is stirred overnight. Distilled water is then added to the reaction mixture, which is then adjusted to pH=5 using hydrochloric acid (1 M). The aqueous phase is separated and extracted with MTB ether. The combined organic phases are washed with saturated sodium bicarbonate solution, dried over sodium sulfate, filtered and evaporated in vacuum. The residue gives 1-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol 17 as yellow crystals.

[0101] <Step 4.4>: 2-[4-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane [ka] Toluene-4-sulfonic acid monohydrate (0.3 g, 2.0 mmol) is added to 1-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]-4-(5-propyl-1,3-dioxan-2-yl)cyclohexanol 17 (10.8 g, 9.9 mmol) in toluene (53 ml) and the mixture is refluxed on a water separator for 2 h. The reaction mixture is cooled to RT, evaporated in vacuum and chromatographed on silica gel (heptane / MTB ether 95:5). After crystallization from 2-propenyl and heptane, 2-[4-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane 18 is isolated as a colorless solid. Compound 18 exhibits the following phase behavior:

[0102] C95Sm213I Δε=30 Δn=0.18

[0103] Example 5: 2-[4-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran [ka]

[0104] <Step 5.1>: 4-(5-propyltetrahydropyran-2-yl)cyclohexanone [ka] 4-(5-propyltetrahydropyran-2-yl)phenol 19 (CAS 879544-24-8, 50.0 g, 227 mmol) is dissolved in xylene (330 ml), Pd / C (5%, 4.4 g) and sodium carbonate (0.2 g, 2.3 mmol) are added and the mixture is hydrogenated under pressure using hydrogen (10.2 l). After 8 h, the solution is filtered and evaporated in vacuum. The crude product is taken up in n-heptane (200 ml), a mixture of sulfur trioxide / pyridine complex (37.0 g, 233 mmol) and Celite (50 g) is added and the mixture is stirred overnight at RT. Then further Celite (20 g) and silica gel (20 g) are added and the mixture is stirred. After 90 min, the reaction mixture is suction filtered. The filtrate is washed with distilled water and saturated sodium bicarbonate solution, dried over sodium sulfate, filtered and evaporated in vacuum. The residue gives 4-(5-propyltetrahydropyran-2-yl)cyclohexanone 20 as a clear yellowish oil.

[0105] <Step 5.2>: 1-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol [ka] A solution of isopropylmagnesium chloride (in THF, 22.9 ml, 46 mmol, 2.0 mol / l) is introduced initially and a solution of 5-(4-bromo-2-fluorophenyl)-1,2,3-trifluorobenzene 4 (7.0 g, 23 mmol) in THF (50 ml) is added dropwise at 30° C. After 60 min, a solution of 4-(5-propyltetrahydropyran-2-yl)cyclohexanone 20 (5.1 g, 23 mmol) in THF (50 ml) is added dropwise at max. 30° C. After another 60 min, distilled water is added to the reaction mixture and the pH=5 is adjusted using hydrochloric acid (1 M). The aqueous phase is separated and extracted with MTB ether. The combined organic phases are washed with saturated sodium bicarbonate solution, dried over sodium sulfate, filtered and evaporated in vacuum. The residue gives 1-[3-fluoro-4-(3,4,5-trifluorophenyl)-phenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol 21 as yellowish crystals.

[0106] <Step 5.3>: 2-[4-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran [ka] Toluene-4-sulfonic acid monohydrate (0.5 g, 3 mmol) is added to a solution of 1-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol 21 (12.2 g, 15 mmol) in toluene (80 ml) and the mixture is refluxed on a water separator for 90 min. The reaction mixture is cooled to RT, diluted with n-heptane and chromatographed on silica gel (heptane / MTB ether 95:5). After recrystallization from 2-propanol and n-heptane, 2-[4-[4-[3-fluoro-4-(3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran 22 is isolated in the form of colorless crystals. Compound 22 exhibits the following phase behavior:

[0107] C95N191I Δε=23 Δn=0.17

[0108] Example 6: 2-[4-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran [ka]

[0109] <Step 6.1>: 1-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol [ka] Isopropylmagnesium chloride (10.8 ml, 22 mmol, 2 mol / l in THF) is initially introduced and a solution of 5-(4-bromo-2-fluorophenyl)-1,3-difluoro-2-(trifluoromethyl)benzene 11 (4.0 g, 11 mmol) in THF (20 ml) is added dropwise at 30° C. After 60 min, a solution of 4-(5-propyltetrahydropyran-2-yl)cyclohexanone 20 (2.5 g, 11 mmol) in THF (15 ml) is added dropwise at max. 20° C. After another 60 min, distilled water is added to the reaction mixture, which is then adjusted to pH=5 using hydrochloric acid (1M). The aqueous phase is separated and extracted with MTB ether. The combined organic phases are washed with saturated sodium bicarbonate solution, dried over sodium sulfate, filtered and evaporated in vacuum. The residue gives 1-[4-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol 23 as yellowish crystals.

[0110] <Step 6.2>: 2-[4-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran [ka] Toluene-4-sulfonic acid monohydrate (0.3 g, 1.5 mmol) in toluene (40 ml) is added to 1-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol 23 (7.1 g, 7 mmol) in toluene (40 ml) and the mixture is refluxed on a water separator for 2 h. The reaction mixture is cooled to RT, evaporated in vacuum and chromatographed on silica gel (heptane / MTB ether 95:5). After crystallization from 2-propanol and n-heptane, 2-[4-[4-[3,5-difluoro-4-(trifluoromethyl)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran 24 is isolated in the form of colorless crystals. Compound 24 exhibits the following phase behavior:

[0111] C98N182I Δε=31 Δn=0.19

[0112] Example 7: 2-[4-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran [ka]

[0113] <Step 7.1>: 1-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol [ka] Isopropylmagnesium chloride (13.1 ml, 26 mmol, 2.0 mol / l in THF) is initially introduced and a solution of 5-(4-bromo-2-fluorophenyl)-1,3-difluoro-2-(trifluoromethoxy)benzene 16 (5.0 g, 13 mmol) in THF (25 ml) is added dropwise at 30° C. After 60 min, a solution of 4-(5-propyltetrahydropyran-2-yl)cyclohexanone 20 (3.0 g, 13 mmol) in THF (37 ml) is added dropwise at max. 20° C. and the mixture is stirred overnight. Distilled water is then added to the reaction mixture, which is then adjusted to pH=5 using hydrochloric acid (1M). The aqueous phase is separated and extracted with MTB ether. The combined organic phases are washed with saturated bicarbonate solution, dried over sodium sulfate, filtered and evaporated in vacuum. The residue gives 1-[4-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol 26 as a yellowish oil.

[0114] <Step 7.2>: 2-[4-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran [ka] Toluene-4-sulfonic acid monohydrate (0.3 g, 2 mmol) is added to a solution of 1-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]-4-(5-propyltetrahydropyran-2-yl)cyclohexanol 26 (8.7 g, 8 mmol) in toluene (40 ml) and the mixture is refluxed on a water separator for 2 h. The reaction mixture is cooled to RT, evaporated in vacuum and chromatographed on silica gel (heptane / MTB ether 95:5). After crystallization from 2-propanol and n-heptane, 2-[4-[4-[3,5-difluoro-4-(trifluoromethoxy)phenyl]-3-fluorophenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran 27 is isolated as a colorless solid. Compound 27 exhibits the following phase behavior:

[0115] C78Sm117N206I Δε=24 Δn=0.18

[0116] The following is prepared similarly:

[0117] <Example 8>: 2-[4-[3-fluoro-4-(2-methyl-3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyl-1,3-dioxane [ka]

[0118] <Example 9>: 2-[4-[3-fluoro-4-(2-methyl-3,4,5-trifluorophenyl)phenyl]cyclohex-3-en-1-yl]-5-propyltetrahydropyran [ka]

Claims

1. A compound of formula I. [Formula 1] (In the formula, X 1 represents F, CF 3 , OCF 3 or -SCN; Y 1 is O or CH 2 represents R 1 represents an alkyl or alkenyl group having up to 8 carbon atoms; L 1 and L 2 represent, independently of one another, H or F, L 3 represents H or F, L 4 represents H or F, and L 5 and L 6 are each independently H or CH 3 Represents.)

2. L 4 2. The compound according to claim 1, wherein:

3. R 1 Compounds according to claim 1 or 2, characterized in that: denotes a straight-chain alkyl group having 1 to 7 C atoms or an unbranched alkenyl group having 2 to 8 C atoms.

4. The compound according to claim 1, wherein R 1 represents unbranched alkyl having 1 to 5 C atoms.

5. X 1 ,F,OCF 3 or CF 3 The compound according to any one of claims 1 to 4, characterized in that it represents

6. L 1 and L 2 The compound according to any one of claims 1 to 5, wherein represents F.

7. Y 1 The compound according to any one of claims 1 to 6, characterized in that: represents O.

8. Y 1 is CH 2 The compound according to any one of claims 1 to 6, characterized in that it represents

9. The compound according to any one of claims 1 to 8, selected from the following formulas: [Case 2] (In the formula, R 1 has the meaning given in claim 1, 3 or 4.

10. The compound according to claim 1, wherein R 1 represents —C 3 H 7 or —C 4 H 9 .

11. A process for preparing a compound of formula I according to any one of claims 1 to 10, comprising the steps of: A process comprising the step of reacting an aryl halide compound of formula II with a compound of formula III to obtain a compound of formula IV which is further converted to a compound of formula I. [C3] (In the formula, X 1 , L 1 , L 2 , L 3 and L 4 is as defined in claim 1, and Hal represents Br, I or Cl. [C4] (In the formula, R 1 and Y 1 is as defined in claim 1. [C5] [C6] (In the formula, group R 1 , Y 1 , L 1 , L 2 , L 3 , L 4 and X 1 is as defined in claim 1.

12. Use of one or more compounds of the formula I according to any one of claims 1 to 10 as constituents in liquid-crystalline media.

13. A liquid crystal medium comprising at least two mesogens, Liquid-crystalline medium, characterized in that it comprises at least one compound of the formula I according to any one of claims 1 to 10.

14. 14. Use of a liquid-crystalline medium according to claim 13 for electro-optical purposes.

15. Electro-optical liquid crystal display comprising a liquid crystal medium according to claim 13.

Citation Information

Patent Citations

  • Liquid crystal compound having tetrahydropyran ring

    JP2007507439A

  • Cyclohexene compounds for liquid crystal mixtures

    JP2010500383A

  • Substituted benzenemethanol compounds, intermediates thereof, and preparation thereof

    US4940822A

  • Liquid-crystalline compounds having a tetrahydropyran ring

    WO2004106460A1

  • Liquid-crystalline compounds

    WO2018141759A1